PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
CD91.DE vs. 4GLD.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

CD91.DE vs. 4GLD.DE

Last updated Apr 2, 2026

Compare and contrast key facts about Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Xetra-Gold ETF (4GLD.DE).

CD91.DE and 4GLD.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CD91.DE is a passively managed fund by Amundi that tracks the performance of the NYSE Arca Gold BUGS. It was launched on Dec 7, 2023. 4GLD.DE is a passively managed fund by Xetra that tracks the performance of the LBMA Gold Price. It was launched on Nov 27, 2007. Both CD91.DE and 4GLD.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

CD91.DE vs. 4GLD.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Xetra-Gold ETF (4GLD.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CD91.DE vs. 4GLD.DE - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
CD91.DE
Amundi NYSE Arca Gold Bugs UCITS ETF Dist		15.48%132.40%20.73%2.42%-1.60%-8.06%15.38%49.81%-12.27%-11.24%
4GLD.DE
Xetra-Gold ETF		10.04%49.32%34.57%9.32%7.12%4.03%13.05%21.25%3.20%-1.67%

Returns By Period

In the year-to-date period, CD91.DE achieves a 15.48% return, which is significantly higher than 4GLD.DE's 10.04% return. Over the past 10 years, CD91.DE has outperformed 4GLD.DE with an annualized return of 16.87%, while 4GLD.DE has yielded a comparatively lower 14.46% annualized return.

CD91.DE

1D
7.27%
1M
-13.37%
YTD
15.48%
6M
34.55%
1Y
112.52%
3Y*
44.76%
5Y*
25.82%
10Y*
16.87%

4GLD.DE

1D
2.84%
1M
-8.96%
YTD
10.04%
6M
25.03%
1Y
42.30%
3Y*
31.29%
5Y*
22.89%
10Y*
14.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Amundi NYSE Arca Gold Bugs UCITS ETF Dist

Xetra-Gold ETF

Often compared with CD91.DE:
CD91.DE vs. GDXCD91.DE vs. IAUCD91.DE vs. PLTRCD91.DE vs. SPMOCD91.DE vs. BNKE.LCD91.DE vs. GLDCD91.DE vs. GLDM
Often compared with 4GLD.DE:
4GLD.DE vs. GLD4GLD.DE vs. PPFB.DE4GLD.DE vs. EGLN.L4GLD.DE vs. SGLN.L4GLD.DE vs. SPY4GLD.DE vs. VUAA.L4GLD.DE vs. SPYM.DE

CD91.DE vs. 4GLD.DE - Expense Ratio Comparison

CD91.DE has a 0.65% expense ratio, which is higher than 4GLD.DE's 0.00% expense ratio.

CD91.DE
Amundi NYSE Arca Gold Bugs UCITS ETF Dist
4GLD.DE
Xetra-Gold ETF

Return for Risk

CD91.DE vs. 4GLD.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CD91.DE
CD91.DE Risk / Return Rank: 9393
Overall Rank
CD91.DE Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
CD91.DE Sortino Ratio Rank: 9393
Sortino Ratio Rank
CD91.DE Omega Ratio Rank: 9090
Omega Ratio Rank
CD91.DE Calmar Ratio Rank: 9595
Calmar Ratio Rank
CD91.DE Martin Ratio Rank: 9393
Martin Ratio Rank
4GLD.DE
4GLD.DE Risk / Return Rank: 8484
Overall Rank
4GLD.DE Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
4GLD.DE Sortino Ratio Rank: 8383
Sortino Ratio Rank
4GLD.DE Omega Ratio Rank: 8383
Omega Ratio Rank
4GLD.DE Calmar Ratio Rank: 8484
Calmar Ratio Rank
4GLD.DE Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CD91.DE vs. 4GLD.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Xetra-Gold ETF (4GLD.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

CD91.DE4GLD.DEDifference

Sharpe ratio

Return per unit of total volatility

2.67

1.77

+0.89

Sortino ratio

Return per unit of downside risk

2.90

2.26

+0.64

Omega ratio

Gain probability vs. loss probability

1.40

1.34

+0.06

Calmar ratio

Return relative to maximum drawdown

4.21

2.60

+1.61

Martin ratio

Return relative to average drawdown

14.68

9.88

+4.80

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CD91.DE vs. 4GLD.DE - Sharpe Ratio Comparison

The current CD91.DE Sharpe Ratio is 2.67, which is higher than the 4GLD.DE Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of CD91.DE and 4GLD.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

CD91.DE4GLD.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.67

1.77

+0.89

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.75

1.43

-0.68

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

1.01

-0.52

Sharpe Ratio (All Time)

Calculated using the full available price history

0.11

0.68

-0.57

Correlation

The correlation between CD91.DE and 4GLD.DE is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

CD91.DE vs. 4GLD.DE - Dividend Comparison

CD91.DE's dividend yield for the trailing twelve months is around 0.12%, while 4GLD.DE has not paid dividends to shareholders.

TTM202520242023202220212020201920182017
CD91.DE
Amundi NYSE Arca Gold Bugs UCITS ETF Dist		0.12%0.14%0.31%2.37%1.05%0.46%0.14%0.30%0.00%0.57%
4GLD.DE
Xetra-Gold ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CD91.DE vs. 4GLD.DE - Drawdown Comparison

The maximum CD91.DE drawdown since its inception was -80.32%, which is greater than 4GLD.DE's maximum drawdown of -36.79%. Use the drawdown chart below to compare losses from any high point for CD91.DE and 4GLD.DE.

Loading graphics...

Drawdown Indicators

CD91.DE4GLD.DEDifference

Max Drawdown

Largest peak-to-trough decline

-80.32%

-36.79%

-43.53%

Max Drawdown (1Y)

Largest decline over 1 year

-27.16%

-16.54%

-10.62%

Max Drawdown (5Y)

Largest decline over 5 years

-39.56%

-16.54%

-23.02%

Max Drawdown (10Y)

Largest decline over 10 years

-55.46%

-18.23%

-37.23%

Current Drawdown

Current decline from peak

-13.37%

-8.96%

-4.41%

Average Drawdown

Average peak-to-trough decline

-46.89%

-11.83%

-35.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.79%

4.35%

+3.44%

Volatility

CD91.DE vs. 4GLD.DE - Volatility Comparison

Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a higher volatility of 17.63% compared to Xetra-Gold ETF (4GLD.DE) at 11.15%. This indicates that CD91.DE's price experiences larger fluctuations and is considered to be riskier than 4GLD.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

CD91.DE4GLD.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.63%

11.15%

+6.48%

Volatility (6M)

Calculated over the trailing 6-month period

35.39%

21.02%

+14.37%

Volatility (1Y)

Calculated over the trailing 1-year period

41.98%

23.76%

+18.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.84%

15.78%

+18.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.57%

14.26%

+20.31%